Literature DB >> 32504327

The Regulatory Role of Reticulons in Neurodegeneration: Insights Underpinning Therapeutic Potential for Neurodegenerative Diseases.

Lilesh Kumar Pradhan1, Saroj Kumar Das2.   

Abstract

In the last few decades, cytoplasmic organellar dysfunction, such as that of the endoplasmic reticulum (ER), has created a new area of research interest towards the development of serious health maladies including neurodegenerative diseases. In this context, the extensively dispersed family of ER-localized proteins, i.e. reticulons (RTNs), is gaining interest because of its regulative control over neural regeneration. As most neurodegenerative diseases are pathologically manifested with the accretion of misfolded proteins with subsequent induction of ER stress, the regulatory role of RTNs in neural dysfunction cannot be ignored. With the limited information available in the literature, delineation of the functional connection between rising consequences of neurodegenerative diseases and RTNs need to be elucidated. In this review, we provide a broad overview on the recently revealed regulatory roles of reticulons in the pathophysiology of several health maladies, with special emphasis on neurodegeneration. Additionally, we have also recapitulated the decisive role of RTN4 in neurite regeneration and highlighted how neurodegeneration and proteinopathies are mechanistically linked with each other through specific RTN paralogues. With the recent findings advocating zebrafish Rtn4b (a mammalian Nogo-A homologue) downregulation following central nervous system (CNS) lesion, RTNs provides new insight into the CNS regeneration. However, there are controversies with respect to the role of Rtn4b in zebrafish CNS regeneration. Given these controversies, the connection between the unique regenerative capabilities of zebrafish CNS by distinct compensatory mechanisms and Rtn4b signalling pathway could shed light on the development of new therapeutic strategies against serious neurodegenerative diseases.

Entities:  

Keywords:  CNS regeneration; Endoplasmic reticulum; Neurodegeneration; Neurodegenerative diseases; Nogo-A; Reticulons; Rtn4b

Mesh:

Substances:

Year:  2020        PMID: 32504327     DOI: 10.1007/s10571-020-00893-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  174 in total

Review 1.  NI-35/250/nogo-a: a neurite growth inhibitor restricting structural plasticity and regeneration of nerve fibers in the adult vertebrate CNS.

Authors:  C E Bandtlow; M E Schwab
Journal:  Glia       Date:  2000-01-15       Impact factor: 7.452

2.  [Relapsing intrapelvic tumors].

Authors:  T Takayanagi
Journal:  Rinsho Byori       Date:  1967-08

3.  Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response.

Authors:  Dae-Gyun Ahn; Tanveer Sharif; Kenneth Chisholm; Devanand M Pinto; Shashi A Gujar; Patrick W K Lee
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

Review 4.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms.

Authors:  Michelle L Block; Luigi Zecca; Jau-Shyong Hong
Journal:  Nat Rev Neurosci       Date:  2007-01       Impact factor: 34.870

5.  Substrate properties of zebrafish Rtn4b/Nogo and axon regeneration in the zebrafish optic nerve.

Authors:  Vsevolod Bodrikov; Cornelia Welte; Marianne Wiechers; Markus Weschenfelder; Gurjot Kaur; Aleksandra Shypitsyna; Alejandro Pinzon-Olejua; Martin Bastmeyer; Claudia A O Stuermer
Journal:  J Comp Neurol       Date:  2017-06-23       Impact factor: 3.215

6.  PirB is a functional receptor for myelin inhibitors of axonal regeneration.

Authors:  Jasvinder K Atwal; Julie Pinkston-Gosse; Josh Syken; Scott Stawicki; Yan Wu; Carla Shatz; Marc Tessier-Lavigne
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

7.  PirB inhibits axonal outgrowth via the PI3K/Akt/mTOR signaling pathway.

Authors:  Yong-Yan Bi; Yong Quan
Journal:  Mol Med Rep       Date:  2017-10-31       Impact factor: 2.952

8.  RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3.

Authors:  Amandine Bastide; Diego Peretti; John R P Knight; Stefano Grosso; Ruth V Spriggs; Xavier Pichon; Thomas Sbarrato; Anne Roobol; Jo Roobol; Davide Vito; Martin Bushell; Tobias von der Haar; C Mark Smales; Giovanna R Mallucci; Anne E Willis
Journal:  Curr Biol       Date:  2017-02-23       Impact factor: 10.834

9.  Activation of sphingosine 1-phosphate receptor-1 by SEW2871 improves cognitive function in Alzheimer's disease model rats.

Authors:  Masoumeh Asle-Rousta; Shahrbanoo Oryan; Abolhassan Ahmadiani; Mehdi Rahnema
Journal:  EXCLI J       Date:  2013-06-03       Impact factor: 4.068

10.  Loss of Nogo-A, encoded by the schizophrenia risk gene Rtn4, reduces mGlu3 expression and causes hyperexcitability in hippocampal CA3 circuits.

Authors:  Stewart Berry; Oliver Weinmann; Ann-Kristina Fritz; Ruslan Rust; David Wolfer; Martin E Schwab; Urs Gerber; Jeanne Ster
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

View more
  4 in total

1.  Curvature sensing amphipathic helix in the C-terminus of RTNLB13 is conserved in all endoplasmic reticulum shaping reticulons in Arabidopsis thaliana.

Authors:  Rhiannon L Brooks; Chandni S Mistry; Ann M Dixon
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

Review 2.  ER Morphology in the Pathogenesis of Hereditary Spastic Paraplegia.

Authors:  Sonia Sonda; Diana Pendin; Andrea Daga
Journal:  Cells       Date:  2021-10-25       Impact factor: 6.600

3.  A deep convolutional neural network for segmentation of whole-slide pathology images identifies novel tumour cell-perivascular niche interactions that are associated with poor survival in glioblastoma.

Authors:  Amin Zadeh Shirazi; Mark D McDonnell; Eric Fornaciari; Guillermo A Gomez; Narjes Sadat Bagherian; Kaitlin G Scheer; Michael S Samuel; Mahdi Yaghoobi; Rebecca J Ormsby; Santosh Poonnoose; Damon J Tumes
Journal:  Br J Cancer       Date:  2021-04-29       Impact factor: 7.640

4.  Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.

Authors:  Gian-Carlo Eyer; Stefano Di Santo; Ekkehard Hewer; Lukas Andereggen; Stefanie Seiler; Hans Rudolf Widmer
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.